Ginkgo BioWorks
Ginkgo BioWorks es una empresa de biología sintética que diseña organismos para fabricar productos específicos, como fármacos, aromas y fragancias, entre otros. La plataforma de la empresa aprovecha la automatización, el software y el análisis de datos para diseñar y optimizar sistemas biológicos. El enfoque innovador de Ginkgo BioWorks está haciendo avanzar la biotecnología en diversos sectores, desde la agricultura hasta la energía.
Gráfico NewsHeat
- Semana
- Mes
- Año
- Noticias de prensa
- Noticias corporativas
Los datos del gráfico anterior se basan en datos derivados de nuestro modelo de cálculo XP patentado y pueden modificarse, ajustarse y actualizarse sin previo aviso.
Valoración de empresas
- Valoración
- Precio de las acciones
- Financiación acumulada
Los datos de los cuadros y gráficos se basan en datos de fuentes públicas y, aunque hacemos todo lo posible por recopilarlos, es posible que no coincidan con los datos reales del emisor.
*** - Para ver los datos, conéctese a su cuenta o cree una nueva.
Noticias relacionadas con Ginkgo BioWorks114
Botswana’s Ministry of Health and Ginkgo Launch Pathogen Monitoring Program at Sir Seretse Khama International Airport | Ginkgo Bioworks
Headquartered in Boston, Ginkgo Bioworks uses the most advanced technology on the planet—biology—to grow better products. Our cell programming platform enables the growth of biotechnology across diverse markets, from food to fragrance to pharmaceuticals....
Ginkgo BioWorkshttps://www.ginkgo.bio/resources/blog/botswanas-ministry-of-health-and-ginkgo-launch-pathogen-monitoring-programGinkgo Biosecurity and Virgin Atlantic Partner for Cutting-Edge Biosecurity | Ginkgo Bioworks
Headquartered in Boston, Ginkgo Bioworks uses the most advanced technology on the planet—biology—to grow better products. Our cell programming platform enables the growth of biotechnology across diverse markets, from food to fragrance to pharmaceuticals....
Ginkgo BioWorkshttps://www.ginkgo.bio/resources/blog/ginkgo-biosecurity-and-virgin-atlantic-partner-for-cutting-edge-biosecurityGinkgo Bioworks Announces Date of First Quarter 2024 Results Presentation - Ginkgo Bioworks
Ginkgo Bioworks Holdings, Inc. (NYSE: DNA, "Ginkgo"), which is building the leading platform for cell programming and biosecurity, today announced that it plans to host a presentation and QA session reviewing business performance for the first quarter end...
Ginkgo BioWorkshttps://www.ginkgobioworks.com/press/ginkgo-bioworks-announces-date-of-first-quarter-2024-results-presentation/Ginkgo Bioworks Announces Nomination of Myrtle Potter and Ross Fubini to Board of Directors - Ginkgo Bioworks
Today, Ginkgo Bioworks (NYSE: DNA ), which is building the leading platform for cell programming and biosecurity, announced the nomination of Myrtle Potter and Ross Fubini for election as independent directors at Ginkgo's upcoming annual meeting, schedule...
Ginkgo BioWorkshttps://www.ginkgobioworks.com/press/ginkgo-bioworks-announces-nomination-of-myrtle-potter-and-ross-fubini-to-board-of-directors/Soaring Eagle Acquisition Corp. stock rallies on approval of Ginkgo ...
Soaring Eagle Acquisition Corp. stock rallies on approval of Ginkgo ......
https://seekingalpha.com/news/3739645-soaring-eagle-acquisition-corp-stock-rallies-on-ginkgo-bioworks-spac-deal